Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Markets React to Uncertainty Over US Election Outcome

(Screenshots via CNN video.) It has been a tumultuous time for the markets, from abrupt deep dips to relief rallies that saw effects to indexes on both sides of the border. US stock futures have been northing short of volatile in the last few days with the president...
Stockhouse Editorial | November 4, 2020 |

Reigniting the Cannabis Oral Delivery System Marketplace

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Dave Jackson was recently joined live with Bra...
Dave Jackson | September 23, 2019 |

US between Scylla and Charybdis

I’m just going to come right out and say it: The United States is not equipped to deal with a pandemic. The nation of 327 million, despite having the number one economy in the world, and by far the most powerful military, is shockingly ill-prepared, not only ...
Richard (Rick) Mills | March 31, 2020 |

Covid19, Bear Markets and Gold

Although I know of some great companies and stocks out there, it is best just to wait. Markets are going a lot lower and investors in the main indexes and techs won't have a recovery in their portfolios for many, many years. Gold is being sold down too at times but the up...
Streetwise Reports | March 13, 2020 |

How a ‘Debt Jubilee’ + mining could be a path to coronavirus recovery

Stock markets rebounded on Tuesday, after the White House announced further measures to help Americans and companies hurt by the coronavirus pandemic. The Trump Administration is reportedly considering sending checks to Americans so they have cash to spend during the outbr...
Richard (Rick) Mills | March 18, 2020 |

A Topical Solution for Chronic Pain

Pain impedes the life of millions around the world, and the market for topical creams to treat this pain is growing at an accelerated rate as people choose to treat pain directly vs ingesting pain killers. Some analysts, such as those at Allied Market Research, project that ...
Jonathon Brown | May 2, 2022 |

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...
Streetwise Reports | January 6, 2020 |

VIDEO: The Next-Gen Student App Targeting Untapped Market

(Click image to play video) Mijem Inc . is a Company that is ready to capitalize on Gen Z; a market with money to spend via either themselves or their parents providing funds to purchase university supplies, clothes, electronics, etc. T...
Featured Submission | January 16, 2020 |

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
Research | 1 day ago |

Economic stimulus can’t save US from deflation and recession

One of the worst weeks on Wall Street mercifully ended on Friday. S&P 500 DJIA Nasdaq After multiple sessions of panic selling, the markets caught an up-draft after US President Trump declared a national emergency over the coronavirus, thus freeing u...
Richard (Rick) Mills | March 16, 2020 |
1 2 3 4 5 6 7 8 9 10 ...